IR@PKUHSC  > 北京大学第一临床医学院  > 泌尿外科
学科主题临床医学
Aberrant methylation and loss of CADM2 tumor suppressor expression is associated with human renal cell carcinoma tumor progression
He, Wei1,2,3; Li, Xuesong1,2,3; Xu, Shuping4; Ai, Junkui5; Gong, Yanqing1,2,3; Gregg, Jennifer L.5; Guan, Ruili1,2,3; Qiu, Wei1,2,3; Xin, Dianqi1,2,3; Gingrich, Jeffrey R.5; Guo, Yinglu1,2,3; Chang, Guimin5
关键词Cadm2 Renal Cell Carcinoma Methylation Tumor Suppressor
刊名BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
2013-06-14
DOI10.1016/j.bbrc.2013.04.074
435期:4页:526-532
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Biochemistry & Molecular Biology ; Biophysics
研究领域[WOS]Biochemistry & Molecular Biology ; Biophysics
关键词[WOS]SUPPRESSOR GENE ; LUNG-CANCER ; HETEROZYGOSITY ; ADHESION
英文摘要

Cell adhesion molecules (CADMs) comprise a protein family whose functions include maintenance of cell polarity and tumor suppression. In this report, we show that the CADM2 gene is repressed in human clear renal cell carcinoma by DNA promoter hypermethylation and/or loss of heterozygosity. Moreover, the loss of CADM2 expression is associated with a higher tumor pathology stage (p < 0.05). The re-expression of CADM2 in the renal cancer cell line 786-O significantly suppressed tumor cell growth in vitro and in mouse xenografts by a G1 phase cell cycle arrest and the induction of apoptosis. Lentivirus-mediated CADM2 expression also significantly suppressed cancer cell anchorage-independent growth and invasion. Furthermore, the inhibition of endogenous CADM2 expression using siRNAs induced a tumorigenic phenotype in polarized non-tumorigenic MDCK cells. Thus, we conclude that CADM2 functions as a novel tumor suppressor and may serve as a potential therapeutic target for human renal cell carcinoma. (c) 2013 Elsevier Inc. All rights reserved.

语种英语
WOS记录号WOS:000321025800004
引用统计
被引频次:18[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/54175
专题北京大学第一临床医学院_泌尿外科
北京大学第一临床医学院_北京大学泌尿外科研究所
作者单位1.Natl Urol Canc Ctr, Beijing 100034, Peoples R China
2.Peking Univ, Inst Urol, Beijing 100034, Peoples R China
3.Peking Univ, Hosp 1, Dept Urol, Beijing 100034, Peoples R China
4.Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA
5.Univ Pittsburgh, Dept Urol, Pittsburgh, PA 15232 USA
推荐引用方式
GB/T 7714
He, Wei,Li, Xuesong,Xu, Shuping,et al. Aberrant methylation and loss of CADM2 tumor suppressor expression is associated with human renal cell carcinoma tumor progression[J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS,2013,435(4):526-532.
APA He, Wei.,Li, Xuesong.,Xu, Shuping.,Ai, Junkui.,Gong, Yanqing.,...&Chang, Guimin.(2013).Aberrant methylation and loss of CADM2 tumor suppressor expression is associated with human renal cell carcinoma tumor progression.BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS,435(4),526-532.
MLA He, Wei,et al."Aberrant methylation and loss of CADM2 tumor suppressor expression is associated with human renal cell carcinoma tumor progression".BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 435.4(2013):526-532.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[He, Wei]的文章
[Li, Xuesong]的文章
[Xu, Shuping]的文章
百度学术
百度学术中相似的文章
[He, Wei]的文章
[Li, Xuesong]的文章
[Xu, Shuping]的文章
必应学术
必应学术中相似的文章
[He, Wei]的文章
[Li, Xuesong]的文章
[Xu, Shuping]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。